ALK, ROS1 and EGFR Next-Generation Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer

Oncology in Clinical Practice - Poland
doi 10.5603/ocp.2018.0042
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

VM Media SP. zo.o VM Group SK


Related search